obesity disorder
obesity disorder
Explore linked clinical trials. Standard reference: MONDO:00111222,557 results · Page 1 of 103
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Post-exercise Blood Pressure With Inorganic Nitrate | Body Weight, Nutritional and Metabolic Diseases, Obesity, Abdominal, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, cardiovascular disorder, hypertensive disorder, nutritional disorder, obesity disorder, overnutrition, vascular disorder | Not yet recruiting | Not applicable | 2026-10-09 | NCT07869472 | |
| BRE-13: Mediterranean Diet | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Not yet recruiting | Not applicable | 2026-10-09 | NCT07869355 | |
| Community Active and Healthy Families Pragmatic Trial | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Pediatric Obesity, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Not yet recruiting | Phase 4 | 2026-10-09 | NCT07868471 | |
| A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Tirzepatide Medication | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus | Not yet recruiting | Phase 1 | 2026-10-09 | NCT07868354 | |
| Exercise Snacks Enabled by an mHealth Intervention Delivered in General Practice to Promote a Sustainable Active Lifestyle in Adults With Obesity | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Not yet recruiting | Not applicable | 2026-10-09 | NCT07867665 | |
| ENDOBARIHEART STUDY | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Not yet recruiting | Not applicable | 2026-10-09 | NCT07847307 | |
| Changes in Intramyocardial Fat Assessed by Cardiac CT Before and After Bariatric Surgery and Their Relationship With Cardiac Diastolic Function | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Not yet recruiting | Not stated | 2026-10-09 | NCT07565610 | |
| A Natural History of Genetic and Environmental Predictors of Pubertal Timing Among Youth With Obesity | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Not yet recruiting | Not stated | 2026-10-09 | NCT07437976 | |
| Evaluation of the Clinical Spectrum of Diabetes and Obesity in Youth and Adults | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperglycemia, metabolic disease, nutritional disorder, obesity disorder, overnutrition | Not yet recruiting | Not stated | 2026-10-09 | NCT07388537 | |
| Efficacy and Safety of Akkermansia Muciniphila AKM Lab-01 for Overweight and Obesity | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Not applicable | 2026-10-09 | NCT07331974 | |
| MASLD in Type 2 Diabetes in Primary Care - a Follow-up Study | Apnea, Atrophy, Body Weight, Dyssomnias, Fibrosis, Insulin Resistance, Neurologic Manifestations, Neuromuscular Manifestations, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Sarcopenia, Signs and Symptoms, Sleep Disorders, Intrinsic, cardiovascular disorder, cirrhosis of liver, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hyperinsulinism, hypertensive disorder, metabolic disease, muscular atrophy, nervous system disorder, nutritional disorder, obesity disorder, obstructive sleep apnea syndrome, overnutrition, respiratory system disorder, sleep apnea syndrome, sleep-wake disorder, type 2 diabetes mellitus, vascular disorder | Enrolling by invitation | Not stated | 2026-10-09 | NCT07312136 | |
| A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus | Active, not recruiting | Phase 2 | 2026-10-09 | NCT07215559 | |
| The COCCOS Study: a Transition Program for Young Persons With Chronic Conditions | Body Weight, Hypersensitivity, Immediate, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Respiratory Hypersensitivity, Signs and Symptoms, asthma, autoimmune disease, bronchial disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, lung disorder, metabolic disease, nutritional disorder, obesity disorder, obstructive lung disease, overnutrition, respiratory system disorder, type 1 diabetes mellitus | Active, not recruiting | Not applicable | 2026-10-09 | NCT07145671 | |
| A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus | Recruiting | Phase 2 | 2026-10-09 | NCT06897475 | |
| Effects of Ultra Processed Food on Intestinal Energy Harvest | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Not applicable | 2026-10-09 | NCT06853288 | |
| Assessing the Impact of Perceptions of Unpredictability on Objective Measures of Food Consumption and Metabolism | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Not yet recruiting | Not stated | 2026-10-09 | NCT06690294 | |
| Continuous Glucose and E-Monitoring to Support Healthy Weight Gain in Pregnancies - The GEM Study | Body Weight, Body Weight Changes, Gestational Weight Gain, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Gain, nutritional disorder, obesity disorder, overnutrition | Recruiting | Not applicable | 2026-10-09 | NCT06666257 | |
| Evaluation of the Metabolic Surgery Technique for Glycemic Improvement in Type 2 Diabetes | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus | Recruiting | Not applicable | 2026-10-09 | NCT06600555 | |
| A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment | Abnormalities, Multiple, Body Weight, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Froelich syndrome, Imprinting Disorders, Male Urogenital Diseases, Neurobehavioral Manifestations, Neurologic Manifestations, Nutritional and Metabolic Diseases, Overweight, Parkes Weber syndrome, Pathological Conditions, Signs and Symptoms, Prader-Willi syndrome, Signs and Symptoms, Urogenital Abnormalities, Urogenital Diseases, chromosomal disorder, disorder of sexual differentiation, endocrine system disorder, gonadal disorder, gonadal dysgenesis, hereditary disease, hypogonadism, intellectual disability, nervous system disorder, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Phase 1 / Phase 2 | 2026-10-09 | NCT06239116 | |
| Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt) | Body Weight, Inflammation, Neoplasms by Site, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, nutritional disorder, obesity disorder, overnutrition, skin disorder | Recruiting | Phase 2 | 2026-10-09 | NCT06150898 | |
| Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity | Body Weight, Insulin Resistance, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, glucose metabolism disease, hyperinsulinism, metabolic disease, nutritional disorder, obesity disorder, overnutrition | Not yet recruiting | Phase 2 | 2026-10-09 | NCT05713799 | |
| Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus | Not yet recruiting | Phase 3 | 2026-10-08 | NCT07866066 | |
| GLP-1 Receptor Agonist Use and Sarcopenia in Obese Individuals Without Diabetes | Atrophy, Body Weight, Neurologic Manifestations, Neuromuscular Manifestations, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, muscular atrophy, nervous system disorder, nutritional disorder, obesity disorder, overnutrition | Recruiting | Not stated | 2026-10-08 | NCT07858864 | |
| A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1) | Apnea, Body Weight, Dyssomnias, Neurologic Manifestations, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Signs and Symptoms, Signs and Symptoms, Respiratory, Sleep Disorders, Sleep Disorders, Intrinsic, nervous system disorder, nutritional disorder, obesity disorder, overnutrition, psychiatric disorder, respiratory system disorder, sleep apnea syndrome, sleep-wake disorder | Recruiting | Phase 3 | 2026-10-08 | NCT07823608 | |
| A Study of LY4329090 in Participants With Obesity or Overweight Who Are Otherwise Healthy | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 1 | 2026-10-08 | NCT07808073 |